Mitotech
PrivateLast Round
Strategic
Jul 16, 2018
Total Funding Raised
$17M
Company Overview
Mitotech is a biotechnology company that develops novel drugs for the treatment of age-related disorders based on mitochondria-targeting cardiolipin peroxidation inhibitors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mitotech Comparables
Compare Mitotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novaliq | 81% | |
| Stuart Therapeutics, Inc. | 79% | |
| Aldeyra Therapeutics | 78% |
Mitotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jul 16, 2018 | ||||
| VC Round | Feb 24, 2010 |
Mitotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Essex Bio-Technology | Strategic |
| Rusnano | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 101% MoM.
- Nov 8, 2025
Monthly visitors grew 89% MoM.
Mitotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mitotech's valuation, stock price, and market status.
Is Mitotech a public or private company?
Mitotech is a private company.
What is the current stock price of Mitotech?
Mitotech is a private company with no public stock price. No recent secondary market data is available.
How much is Mitotech worth (valuation)?
Valuation information for Mitotech is not publicly available.
Can I buy Mitotech stock?
Mitotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Mitotech's last funding round?
Mitotech's most recent funding round was Strategic on July 16, 2018.
Who are the main investors in Mitotech?
Key investors in Mitotech include Essex Bio-Technology, Rusnano.
Will Mitotech IPO soon?
No public IPO plans have been announced for Mitotech.
How can I track Mitotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mitotech's secondary market activity and sign up for updates.